PMID- 26887388 OWN - NLM STAT- MEDLINE DCOM- 20171026 LR - 20181113 IS - 1479-6813 (Electronic) IS - 0952-5041 (Print) IS - 0952-5041 (Linking) VI - 56 IP - 3 DP - 2016 Apr TI - Regulation of liver development: implications for liver biology across the lifespan. PG - R115-25 LID - 10.1530/JME-15-0313 [doi] AB - The liver serves a spectrum of essential metabolic and synthetic functions that are required for the transition from fetal to postnatal life. Processes essential to the attainment of adequate liver mass and function during fetal life include cell lineage specification early in development, enzymic and other functional modes of differentiation throughout gestation, and ongoing cell proliferation to achieve adequate liver mass. Available data in laboratory rodents indicate that the signaling networks governing these processes in the fetus differ from those that can sustain liver function and mass in the adult. More specifically, fetal hepatocytes may develop independent of key mitogenic signaling pathways, including those involving the Erk mitogen-activated protein kinases MAPK1/3 and the mechanistic target of rapamycin (mTOR). In addition, the fetal liver is subject to environmental influences that, through epigenetic mechanisms, can have sustained effects on function and, by extension, contribute to the developmental origin of adult metabolic disease. Finally, the mitogen-independent phenotype of rat fetal hepatocytes in late gestation makes these cells suitable for cell-based therapy of liver injury. In the aggregate, studies on the mechanisms governing fetal liver development have implications not only for the perinatal metabolic transition but also for the prevention and treatment of liver disorders throughout the lifespan. CI - (c) 2016 Society for Endocrinology. FAU - Gruppuso, Philip A AU - Gruppuso PA AD - Division of Pediatric EndocrinologyRhode Island Hospital and Brown University, Providence, RI, USA Department of Molecular BiologyCell Biology and Biochemistry, Brown University, Providence, RI, USA Philip_Gruppuso@brown.edu. FAU - Sanders, Jennifer A AU - Sanders JA AD - Division of Pediatric EndocrinologyRhode Island Hospital and Brown University, Providence, RI, USA Department of Pathology and Laboratory MedicineBrown University, Providence, RI, USA. LA - eng GR - R01 DK100301/DK/NIDDK NIH HHS/United States GR - R01 HD024455/HD/NICHD NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Review DEP - 20160217 PL - England TA - J Mol Endocrinol JT - Journal of molecular endocrinology JID - 8902617 RN - 0 (Insulin) RN - 0 (Intercellular Signaling Peptides and Proteins) SB - IM MH - Animals MH - Cell Differentiation MH - Cell Lineage MH - Cell- and Tissue-Based Therapy MH - Female MH - Gene Expression Regulation, Developmental MH - Hepatocytes/cytology/metabolism MH - Humans MH - Insulin/genetics/metabolism MH - Intercellular Signaling Peptides and Proteins/genetics/metabolism MH - Liver/*embryology/growth & development/*physiology MH - Liver Diseases/etiology/metabolism/therapy MH - Maternal Nutritional Physiological Phenomena MH - *Organogenesis MH - Phenotype MH - Primates MH - Rats MH - Signal Transduction PMC - PMC4882189 MID - NIHMS788176 OTO - NOTNLM OT - development OT - epigenetics OT - growth factors OT - insulin action OT - metabolism COIS- Declaration of Interest The authors have no conflicts of interest to report. EDAT- 2016/02/19 06:00 MHDA- 2017/10/27 06:00 PMCR- 2017/04/01 CRDT- 2016/02/19 06:00 PHST- 2016/02/11 00:00 [received] PHST- 2016/02/16 00:00 [accepted] PHST- 2016/02/19 06:00 [entrez] PHST- 2016/02/19 06:00 [pubmed] PHST- 2017/10/27 06:00 [medline] PHST- 2017/04/01 00:00 [pmc-release] AID - JME-15-0313 [pii] AID - 10.1530/JME-15-0313 [doi] PST - ppublish SO - J Mol Endocrinol. 2016 Apr;56(3):R115-25. doi: 10.1530/JME-15-0313. Epub 2016 Feb 17.